Efficacy and safety of long-acting GLP-1receptor agonist semaglutide for type 2 diabetes patients: a systematic review

Lu Zhiwei; Sun Hao; Zhao Zhenyu; Li Ying; Xiao Longke; Dong Yan; Liu Aina

首页> 外文期刊>Diabetes/metabolism research and reviews >Efficacy and safety of long-acting GLP-1receptor agonist semaglutide for type 2 diabetes patients: a systematic review

【24h】

Efficacy and safety of long-acting GLP-1receptor agonist semaglutide for type 2 diabetes patients: a systematic review

机译：用于2型糖尿病患者的长效GLP-1receptor Agonist Semaglutide的疗效和安全性：系统审查

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetes/metabolism research and reviews 》 |2019年第s1期| 共2页
作者
Lu Zhiwei; Sun Hao; Zhao Zhenyu; Li Ying; Xiao Longke; Dong Yan; Liu Aina;
展开▼
作者单位

Tianjin Med Univ Metab Dis Hosp Res Inst Endocrinol Pharm Key Lab Hormones &

Dev Minist Hlth;

Tianjin Med Univ Metab Dis Hosp Res Inst Endocrinol Pharm Key Lab Hormones &

Dev Minist Hlth;

Tianjin Med Univ Metab Dis Hosp Res Inst Endocrinol Pharm Key Lab Hormones &

Dev Minist Hlth;

Tianjin Med Univ Metab Dis Hosp Res Inst Endocrinol Pharm Key Lab Hormones &

Dev Minist Hlth;

Tianjin Med Univ Metab Dis Hosp Res Inst Endocrinol Pharm Key Lab Hormones &

Dev Minist Hlth;

Tianjin Med Univ Metab Dis Hosp Res Inst Endocrinol Pharm Key Lab Hormones &

Dev Minist Hlth;

Tianjin Med Univ Metab Dis Hosp Res Inst Endocrinol Pharm Key Lab Hormones &

Dev Minist Hlth;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of long-acting GLP-1receptor agonist semaglutide for type 2 diabetes patients: a systematic review [J] . Lu Zhiwei, Sun Hao, Zhao Zhenyu, Diabetes/metabolism research and reviews . 2019 ,第S1期

机译：用于2型糖尿病患者的长效GLP-1receptor Agonist Semaglutide的疗效和安全性：系统审查
2. Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis. [J] . Nicole R Pinelli, Kathryn M Hurren The annals of pharmacotherapy . 2011 ,第7a8期

机译：长效胰高血糖素样肽1受体激动剂与艾塞那肽每天两次和西他列汀在2型糖尿病中的疗效和安全性：系统评价和荟萃分析。
3. Comparing the Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists with Sodium-Glucose Cotransporter 2 Inhibitors for Obese Type 2 Diabetes Patients Uncontrolled on Metformin: A Systematic Review and Meta-Analysis of Randomized Clinical Trials [J] . Lu Ding, Bang Sun, Xinhua Xiao International journal of endocrinology . 2020 ,第2期

机译：比较胰高血糖素肽1受体激动剂与钠葡萄糖Cotroangerporter 2抑制剂的肥胖型糖尿病患者的疗效和安全性，对二甲双胍的不受控制的糖尿病患者：随机临床试验的系统审查和荟萃分析
4. Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator^* [C] . Roberto Visentin, Michele Schiavon, Clemens Giegerich, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018

机译：长效胰岛素在糖尿病治疗中的作用：采用UVA / Padova 1型糖尿病模拟器的Silico临床试验^*
5. Risk of Any Hypoglycemia with New Antihyperglycemic Agents in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis [D] . Kamalinia, Sanaz. 2019

机译：患有2型糖尿病患者的新抗血糖药物的任何低血糖症的风险：系统审查和荟萃分析
6. Comparing the Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists with Sodium-Glucose Cotransporter 2 Inhibitors for Obese Type 2 Diabetes Patients Uncontrolled on Metformin: A Systematic Review and Meta-Analysis of Randomized Clinical Trials [O] . Lu Ding, Bang Sun, Xinhua Xiao 2020

机译：比较胰高血糖素肽1受体激动剂与钠葡萄糖Cotroangerporter 2抑制剂的肥胖型糖尿病患者的疗效和安全性对二甲双胍的不受控制的糖尿病患者：随机临床试验的系统审查和荟萃分析
7. Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy [O] . Eugene E. Wright Jr, Vanita R. Aroda 2020

机译：临床综述2型糖尿病患者的口腔半蛋白质疗效和安全性，考虑注射GLP-1受体激动剂治疗或目前胰岛素治疗

Efficacy and safety of long-acting GLP-1receptor agonist semaglutide for type 2 diabetes patients: a systematic review

著录项

相似文献

相关主题

期刊订阅